Published Date: 15 Jan 2024
News, features, and commentary about cancer-related issues.
Read Full NewsA randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.
A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.
1.
Bayer is transforming pharmaceutical research into women's health
2.
Palliative Care Remains Uncommon in Young Adults With Cancer
3.
Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.
4.
Trial Supports Ivonescimab and Chemo for NSCLC Survival
5.
healthy despite having advanced cancer.
1.
Modern Strategies in Hematology for Specialists
2.
Clinical Insights in Hematology in Daily Practice
3.
Understanding Carcinoid Tumors: Diagnosis, Symptoms, and Treatment Options
4.
Tumor Evolution Dynamics and Clinical Prognosis
5.
Reconstructive Tissue Engineering After Tumor Resection
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
2.
Thromboprophylaxis In Medical Settings- An Update
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
5.
Efficient Management of First line ALK-rearranged NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation